New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin
Author:
Publisher
Informa UK Limited
Subject
Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1586/erc.10.35
Reference54 articles.
1. Prevention of Venous Thromboembolism
2. Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
3. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
4. New Insights Into Cancer-Associated Thrombosis
5. Management of Venous Thromboembolism: A Systematic Review for a Practice Guideline
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine;Biomedicine & Pharmacotherapy;2021-07
2. Heparin mimetics as tools for modulation of biology and therapy;Carbohydrates in Drug Discovery and Development;2020
3. Low molecular weight heparins and their clinical applications;Progress in Molecular Biology and Translational Science;2019
4. Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial;Clinical Drug Investigation;2017-12-06
5. Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells;Gene;2016-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3